one hundred and forty-one patients with rheumatoid arthritis treated with aurothiopropanol sulphonate or d-penicillamine , or both were examined for hla antigens to investigate the genetic influence on the occurrence of different adverse reactions during therapy .
C0003873
rheumatoid arthritis
C0030817
penicillamine